Skip to content

Effect of transcutaneous electrical nerve stimulation for treating patients with refractory overactive bladder syndrome

Effect of transcutaneous electrical nerve stimulation for treating patients with refractory overactive bladder syndrome evaluated by bladder diary and patient satisfaction assessment

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000445976
Enrollment
40
Registered
2011-05-02
Start date
2003-12-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Overactive bladder syndrome (OAB) is highly prevalent and affects the lives of millions of people worldwide. Although antimuscarinics are the pharmacological treatment of choice for OAB, the effectiveness is limited. Thus, there is an urgent need for effective, well-tolerated therapeutic alternatives. Transcutaneous electrical nerve stimulation (TENS) is an established treatment for OAB in children and may also be a valuable option in adults. We therefore aimed to investigate the effect of TENS for treating adult patients with refractory OAB.

Interventions

Transcutaneous electrical nerve stimulation (TENS) for treating patients with refractory overactive bladder syndrome is performed with an Elpha 4 Conti stimulation device applying vaginal electrodes in women and circular penile electrodes in men, the treatment period is 12 weeks stimulating for 20 minutes twice a day (once in the morning, once in the evening).

Sponsors

Department of Urology
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

OAB with urodynamically proven detrusor overactivity, failed behavioural treatment and pharmacotherapy with at least 2 antimuscarinics for a minimum of 1 month, and no previous surgery for OAB

Exclusion criteria

pregancy, age <18 years, not fulfilling inclusion criteria

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026